These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: results of a systematic review. Fidder HH, Singendonk MM, van der Have M, Oldenburg B, van Oijen MG. World J Gastroenterol; 2013 Jul 21; 19(27):4344-50. PubMed ID: 23885145 [Abstract] [Full Text] [Related]
12. SB5: An Adalimumab Biosimilar. Frampton JE. BioDrugs; 2018 Oct 21; 32(5):507-510. PubMed ID: 30251234 [Abstract] [Full Text] [Related]
18. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease. Condamina M, Diaz E, Jamart C, Loget J, Durlach A, Salmon JH, Cadiot G, Viguier M. J Crohns Colitis; 2020 May 21; 14(4):538-542. PubMed ID: 31589303 [Abstract] [Full Text] [Related]